ADMA Biologics Inc (ADMA): if anyone accumulates more than 10% of t...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

ADMA Biologics Inc (ADMA)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	51
Posts	8991
Boards Moderated	1
Alias Born	10/25/2007

Re: None

Wednesday, 12/29/2021 1:08:58 PM

Wednesday, December 29, 2021 1:08:58 PM

if anyone accumulates more than 10% of the shares without the approval of the company, then has to pay a great deal of compensation to all the shareholders (except itself). The interesting part is that the current "poison pill" has a duration of 6 months, unlike the previous one (1 year). The management is trying to underline that there is a concrete possibility of selling the company.

Raymond James : raised ADMA to a Strong Buy, target $5, Bull Case $7. This stock looks like a free ATM machine at the current price!

many big buyers are coming in$$$$

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ADMA News

ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:05:40 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 03/11/2024 04:19:55 PM
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM® • GlobeNewswire Inc. • 03/11/2024 11:00:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:00:40 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:05:30 PM
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference • GlobeNewswire Inc. • 03/05/2024 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 02:00:34 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:00:51 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:00:49 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:00:46 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:00:45 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:00:43 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:00:43 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:21:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:15:33 PM
ADMA Biologics Announces CFO Transition • GlobeNewswire Inc. • 02/28/2024 09:10:00 PM
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/28/2024 09:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 02:00:25 AM
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 • GlobeNewswire Inc. • 02/21/2024 09:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 01:00:18 PM
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics • GlobeNewswire Inc. • 02/21/2024 12:00:00 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 04:50:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:00:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:30:30 PM

More ADMA News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow